Physician

Manuel David Camejo, M.D.

According to 2025 Medicare claims, Manuel Camejo, M.D. (NPI: 1003250606) practices ophthalmology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Jackson, MO. This provider's primary affiliated billing organization is SABATES EYE CENTERS LLC (NPI: 1790749810; TIN: 430955525) and primary practice location at 64055-6957. Camejo is affiliated with the Aledade 98 MO MSSP Enhanced (ACO ID: A4998), participating under the MSSP model.

Camejo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 903 traditional Medicare patients, billed 8,716 HCPCS/CPT codes, and received $1,038,611 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,055 prescription claims across 368 beneficiaries totaling $66,878 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 23 records totaling $588. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $73,965 to $1,038,611. Similarly, Part D prescription costs have moved sharply higher in recent years, from $14,725 to $66,878. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$523K$1.0M2018 Medicare payment: $73,965 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $258,845 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $758,159 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $743,711 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $783,638 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,046,661 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,038,611 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018204747$73,965
20197862,774$258,845
20201,1885,248$758,159
20219995,266$743,711
20228805,063$783,638
20239147,029$1,046,661
20249038,716$1,038,611

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$43K$86K2015 Drug cost: $14,725 (USD; Tot_Drug_Cst)2016 Drug cost: $7,448 (USD; Tot_Drug_Cst)2017 Drug cost: $7,532 (USD; Tot_Drug_Cst)2018 Drug cost: $2,752 (USD; Tot_Drug_Cst)2019 Drug cost: $18,914 (USD; Tot_Drug_Cst)2020 Drug cost: $40,779 (USD; Tot_Drug_Cst)2021 Drug cost: $73,553 (USD; Tot_Drug_Cst)2022 Drug cost: $79,331 (USD; Tot_Drug_Cst)2023 Drug cost: $85,939 (USD; Tot_Drug_Cst)2024 Drug cost: $66,878 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201589277$14,725
201639130$7,448
201754182$7,532
20182448$2,752
2019119275$18,914
2020202496$40,779
2021291740$73,553
2022317823$79,331
20233521,055$85,939
20243681,055$66,878

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye178867$83
92014Established patient complete exam of visual system626638$77
92012Established patient problem focused exam of visual system412695$60
J9035Injection, bevacizumab, 10 mg83409$55
92134Imaging of retina6361,032$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine15930$19,426
Prednisolone AcetatePrednisolone Acetate3748,841$10,468
CyclosporineCyclosporine161,125$9,266
CombiganBrimonidine Tartrate/Timolol221,192$7,197
SimbrinzaBrinzolamide/Brimonidine Tart271,212$5,344

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.23$588Carl Zeiss Meditec USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Manuel David Camejo, M.D.?

Tedicare shows public-source Medicare data for Manuel David Camejo, M.D. (NPI 1003250606), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Manuel David Camejo, M.D. have ACO affiliation data?

Manuel David Camejo, M.D. is shown with ACO affiliation data for Aledade 98 MO MSSP Enhanced (MSSP, ACO ID A4998).

What billing organization is linked to Manuel David Camejo, M.D.?

Manuel David Camejo, M.D. is linked to SABATES EYE CENTERS LLC (billing NPI 1790749810) in the available physician profile data.

Does Manuel David Camejo, M.D. have Open Payments data?

Manuel David Camejo, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.